Abstract

Simple SummaryHorse chromosomes have been studied for veterinary diagnostic purposes for over half a century. The findings show that changes in the chromosome number or structure are among the most common non-infectious causes of decreased fertility, infertility, and developmental abnormalities. Based on large-scale surveys, almost 30% of horses with reproductive or developmental problems have abnormal chromosomes. For a comparison, only 2–5% of horses in the general population have abnormal chromosomes. Most chromosome abnormalities are rare and found in one or a few animals. However, two conditions are recurrent: sterile mares with only one X chromosome, instead of two, and sterile mares with XY male sex chromosomes where the Y has lost the ‘maleness’ gene SRY. The two are signature features of chromosome abnormalities in the horse, being rare or absent in other domestic animals. The progress in horse genome sequencing and the development of molecular tools have improved the depth and quality of diagnostic chromosome analysis, allowing for an understanding of the underlying molecular mechanisms. Nevertheless, cutting-edge genomics tools are not about to entirely replace traditional chromosome analysis, which still is the most straightforward, cost-effective, and fastest approach for the initial evaluation of potential breeding animals and horses with reproductive or developmental disorders.Clinical cytogenetic studies in horses have been ongoing for over half a century and clearly demonstrate that chromosomal disorders are among the most common non-infectious causes of decreased fertility, infertility, and congenital defects. Large-scale cytogenetic surveys show that almost 30% of horses with reproductive or developmental problems have chromosome aberrations, whereas abnormal karyotypes are found in only 2–5% of the general population. Among the many chromosome abnormalities reported in the horse, most are unique or rare. However, all surveys agree that there are two recurrent conditions: X-monosomy and SRY-negative XY male-to-female sex reversal, making up approximately 35% and 11% of all chromosome abnormalities, respectively. The two are signature conditions for the horse and rare or absent in other domestic species. The progress in equine genomics and the development of molecular tools, have qualitatively improved clinical cytogenetics today, allowing for refined characterization of aberrations and understanding the underlying molecular mechanisms. While cutting-edge genomics tools promise further improvements in chromosome analysis, they will not entirely replace traditional cytogenetics, which still is the most straightforward, cost-effective, and fastest approach for the initial evaluation of potential breeding animals and horses with reproductive or developmental disorders.

Highlights

  • Clinical cytogenetic research in horses has been ongoing for over half a century and has clearly demonstrated that chromosome abnormalities are associated with congenital disorders, embryonic loss, reduced fertility, and infertility

  • During the peak of equine clinical cytogenetics in the 1970s–1990s, many abnormal karyotypes were published and in the following years, and the findings have been wellreviewed in books [1,2], book chapters [3,4,5,6,7], and multiple review papers, some focusing on equine cytogenetics [8,9,10], others on cytogenetics of domestic animals, including the horse [11,12,13,14]

  • In addition to bacterial artificial chromosome (BAC) and chromosome painting probes, fluorescence in situ hybridization (FISH) probes are available for vertebrate telomeric repeats (Discovery®: https://www.discoverypeptides.com/pna/ pna-telomere-fish-probes accessed on 1 March 2021), multicopy 18S-5.8S-28S ribosomal DNA sequences [33], known as nucleolus organizer regions (NORs), and horse centromeres [172]

Read more

Summary

Introduction

Clinical cytogenetic research in horses has been ongoing for over half a century and has clearly demonstrated that chromosome abnormalities are associated with congenital disorders, embryonic loss, reduced fertility, and infertility. In cases where chromosomal aberrations do not show phenotypic or behavioral effects, the carriers can be included in breeding, resulting in significant economic loss due to veterinary fees and the costs related to maintaining a sterile or a subfertile horse over the years. During the peak of equine clinical cytogenetics in the 1970s–1990s, many abnormal karyotypes were published and in the following years, and the findings have been wellreviewed in books [1,2], book chapters [3,4,5,6,7], and multiple review papers, some focusing on equine cytogenetics [8,9,10], others on cytogenetics of domestic animals, including the horse [11,12,13,14].

Application of Different Chromosome Banding Techniques
Karyotype Features and Chromosome Nomenclature
Sex Chromosome Aneuploidies
Methods
Structural Rearrangements
Chimerism
Molecular Cytogenetic Methods and Applications
Application of FISH in Horse Clinical Cytogenetics
Cytogenetic Evaluation of Stallions by Sperm-FISH
Whole Genome Analysis by Comparative Genomic Hybridization and Sequencing
Immunolocalization of Chromosomal Proteins
STR Genotyping in Cytogenetics—Advantages and Limitations
Findings
Summary and Future Directions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call